January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Aggressive Lymphoma after CD19 CAR T-Cell Therapy suggested by Vivek Subbiah
Oct 11, 2024, 15:13

Aggressive Lymphoma after CD19 CAR T-Cell Therapy suggested by Vivek Subbiah

Vivek Subbiah shared a post on X:

Aggressive Lymphoma after CD19 CAR T-Cell Therapy clonal hematopoiesis had contributed to lymphomagenesis.”

Aggressive Lymphoma after CD19 CAR T-Cell Therapy

Authors: Guido Kobbe, et al.

Aggressive Lymphoma after CD19 CAR T-Cell Therapy suggested by Vivek Subbiah

Source: Vivek Subbiah/X

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.